BR0006024A - Composition for the treatment of inflammation and pain in mammals - Google Patents

Composition for the treatment of inflammation and pain in mammals

Info

Publication number
BR0006024A
BR0006024A BR0006024-0A BR0006024A BR0006024A BR 0006024 A BR0006024 A BR 0006024A BR 0006024 A BR0006024 A BR 0006024A BR 0006024 A BR0006024 A BR 0006024A
Authority
BR
Brazil
Prior art keywords
pain
inflammation
mammals
composition
treatment
Prior art date
Application number
BR0006024-0A
Other languages
Portuguese (pt)
Inventor
Kim Carieton Krumhar
Lyra Heller
Original Assignee
Metagenics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/519,527 external-priority patent/US6534086B1/en
Application filed by Metagenics Inc filed Critical Metagenics Inc
Publication of BR0006024A publication Critical patent/BR0006024A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSIçãO PARA O TRATAMENTO DE INFLAMAçãO E DOR EM MAMìFEROS". Uma composição para tratar inflamação e dor em mamíferos, particularmente seres humanos. Quantidades eficazes de um ácido boswélico, um curcuminóide, um gingerol, um capsaicinóide, um bioflavonóide, e uma fonte de vitamina C, em várias combinações, todas preferivelmente de uma fonte botânica, são misturadas para formar uma dose para administração oral. A administração da dose provê alívio de dor e inflamação de tecido conectivo. A dose pode ser administrada como um comprimido, um líquido ou um pó."COMPOSITION FOR THE TREATMENT OF INFLAMMATION AND PAIN IN MAMMALS". A composition to treat inflammation and pain in mammals, particularly humans. Effective amounts of a boswellic acid, a curcuminoid, a gingerol, a capsaicinoid, a bioflavonoid, and a source of vitamin C, in various combinations, all preferably from a botanical source, are mixed to form a dose for oral administration. The administration of the dose provides relief from pain and inflammation of connective tissue. The dose can be administered as a tablet, liquid or powder.

BR0006024-0A 1999-04-08 2000-04-10 Composition for the treatment of inflammation and pain in mammals BR0006024A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28819299A 1999-04-08 1999-04-08
US09/519,527 US6534086B1 (en) 2000-03-06 2000-03-06 Composition and method for treatment of inflammation and pain in mammals
PCT/US2000/009530 WO2000059523A1 (en) 1999-04-08 2000-04-10 Composition and method for treatment of inflammation and pain in mammals

Publications (1)

Publication Number Publication Date
BR0006024A true BR0006024A (en) 2001-11-06

Family

ID=26964882

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0006024-0A BR0006024A (en) 1999-04-08 2000-04-10 Composition for the treatment of inflammation and pain in mammals

Country Status (6)

Country Link
EP (1) EP1093376A1 (en)
AU (1) AU4224600A (en)
BR (1) BR0006024A (en)
CA (1) CA2334621A1 (en)
MX (1) MXPA00012314A (en)
WO (1) WO2000059523A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001085183A2 (en) * 2000-05-08 2001-11-15 N.V. Nutricia Preparation for the prevention and treatment of ocular disorders
EP1180331B1 (en) * 2000-08-16 2008-07-09 Unilever N.V. Blends of isoflavones and flavones
ES2309030T3 (en) 2000-08-16 2008-12-16 Unilever N.V. MIXTURES OF ISOFLANONES AND FLAVONES.
DE10041217A1 (en) * 2000-08-22 2002-03-14 Henkel Kgaa Use of dihydroboswellic acids or hydrogenated extracts from Boswellia for the prophylactic and / or therapeutic treatment of undesirable physical or mental conditions
JP4553224B2 (en) 2000-10-20 2010-09-29 有限会社大長企画 healthy food
JP4609875B2 (en) * 2001-07-31 2011-01-12 有限会社大長企画 healthy food
US7972632B2 (en) 2003-02-28 2011-07-05 Unigen Pharmaceuticals, Inc. Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
US7108868B2 (en) 2002-03-22 2006-09-19 Unigen Pharmaceuticals, Inc. Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
US8034387B2 (en) 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
JP4723239B2 (en) 2002-04-30 2011-07-13 ユニジェン・インコーポレーテッド Formulation of a mixture of free-B-ring flavonoids and flavans as therapeutic agents
US8945518B2 (en) * 2002-04-30 2015-02-03 Unigen, Inc. Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
WO2004075844A2 (en) 2003-02-26 2004-09-10 Unigen Pharmaceuticals, Inc. Formulation for use in the prevention and treatment of carbohydrate induced diseases and conditions
AU2004228021B2 (en) 2003-04-04 2010-09-02 Unigen, Inc. Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care
WO2005099686A1 (en) * 2004-04-07 2005-10-27 Fujicco Co., Ltd. Edible composition having effects of promoting the production and release of calcitonin gene-related peptide
DK1890546T3 (en) 2005-05-30 2019-03-11 Benny Antony Process for improving the bioavailability of curcumin
US10286027B2 (en) 2005-05-30 2019-05-14 Arjuna Natural Extracts, Ltd. Sustained release formulations of curcuminoids and method of preparation thereof
US10543277B2 (en) 2005-05-30 2020-01-28 Arjuna Natural Private Limited Formulation of curcumin with enhanced bioavailability of curcumin and method of preparation and treatment thereof
CA2615444A1 (en) * 2005-07-15 2007-01-25 Donald J. Baker Compositions and methods for treating and preventing inflammatory and/or degenerative processes in humans and other animals
CN101505769A (en) * 2006-06-30 2009-08-12 皮瑞缪生命科学有限公司 Herbal compositions for the treatment of diseases of the oral cavity
KR100761248B1 (en) 2006-10-12 2007-10-04 주식회사 유니젠 Composition for treating atopic dermatitis comprising extracts of bamboo and scutellaria
WO2008120220A1 (en) * 2007-04-03 2008-10-09 Ganga Raju Gokaraju Synergistic anti-inflammatory and antioxidant dietary supplement compositions
JP2013519664A (en) * 2010-02-15 2013-05-30 ライラ ニュートラシューティカルズ Novel boswellia low polar rubber resin extract and its synergistic composition
CN104274780A (en) * 2014-10-24 2015-01-14 青岛科技大学 Buccal tablets by taking vitamin C and curcumin as main drug components
CN104382009A (en) * 2014-10-24 2015-03-04 青岛科技大学 Health care tablets using VC and curcumin as components of main drugs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5494668A (en) * 1994-07-11 1996-02-27 Patwardhan; Bhushan Method of treating musculoskeletal disease and a novel composition therefor

Also Published As

Publication number Publication date
CA2334621A1 (en) 2000-10-12
AU4224600A (en) 2000-10-23
EP1093376A1 (en) 2001-04-25
MXPA00012314A (en) 2002-10-23
WO2000059523A1 (en) 2000-10-12

Similar Documents

Publication Publication Date Title
BR0006024A (en) Composition for the treatment of inflammation and pain in mammals
US6579543B1 (en) Composition for topical application to skin
Knuesel et al. Arnica montana gel in osteoarthritis of the knee: an open, multicenter clinical trial
Morelli et al. Alternative therapies for traditional disease states: osteoarthritis
US8613961B1 (en) Dermatological cream with natural ingredients base
CA2518965A1 (en) Homeopathic formulations useful for treating pain and/or inflammmation
US20090082738A1 (en) Natural Anti-Inflammatory Agents for Reducing Pain
BRPI0418681A (en) a dietary supplement for the treatment and prevention of diseases of the digestive system and diseases related to the digestive system and method of production and administration thereof.
US20230346869A1 (en) Formulation for management of post-oral surgical recovery and maintenance of oral health
US20120082739A1 (en) Compositions and Methods for Treatment and Management of Pain
Kriplani et al. Recent patents on anti-cancer potential of helenalin
Dayanarayana et al. Non surgical approaches in treatment of OSF
US8962045B2 (en) Herbal/organic composition for the management of pain
WO2004047717A2 (en) Topical application of curcumin for the treatment of peripheral neuropathy
Amin et al. Aloe Vera: a miracle plant with its wide-ranging applications
Shahare et al. Herbs used in treatment of mouth ulcer-a review
Abraham et al. Management of psoriasis-ayurveda and allopathy—A review
CN112867540A (en) Ozonized phytotherapeutic compositions for tissue and bone regeneration
US9028888B2 (en) Compositions and methods for treatment and management of pain
WO2012059874A1 (en) A mouthwash composition for managing oral mucositis, process and methods thereof
Sharma et al. Evaluation of the efficacy and safety of Rumalaya gel in the management of acute and chronic inflammatory musculoskeletal disorders: An open, prospective, noncomparative, phase III clinical trial'
Nithin et al. Aloevera” the herbal product in dentistry
Maendel BEYOND​ OSTEOPATHIC MANUAL THERAPY
WO2014197129A2 (en) Compositions and methods for treatment and management of pain
WO2020197041A1 (en) Injectable and cosmetic compositions comprising lemon balm extract as active ingredient

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired
B15K Others concerning applications: alteration of classification

Ipc: A61K 36/324 (2006.01), A61K 36/752 (2006.01), A61K